G-NiiB launches the world’s first anti-viral Gut Microbiome formula in Singapore
Therapeutics | News | 0 Comment | 15 Mar, 2022
GenieBiome (G-NiiB), a biotechnology spin-off of The Chinese University of Hong Kong (CUHK), announces the launch of G-N...Read more
Australia to use mRNA technology to research global public health threats
Therapeutics | News | 0 Comment | 11 Mar, 2022
The University of Queensland (UQ), in Australia, has been selected as one of the first launch institutions in the world ...Read more
Hong Kong-based Insilico Medicine focuses on discovery of potential therapeutics for Cystinosis
Therapeutics | News | 0 Comment | 10 Mar, 2022
The MIKADO group, a translational team at the University of Zurich (UZH) focused on generating evidence-driven...Read more
Singapore set to develop antibodies for infectious diseases and cancer treatments
Therapeutics | News | 0 Comment | 10 Mar, 2022
Singapore-based SCG Cell Therapy Pte Ltd (“SCG”), a leading biotechnology company, has signed a collaboratio...Read more
Singapore designs preclinical model to strategise treatment for a genetic kidney disease
Therapeutics | News | 0 Comment | 10 Mar, 2022
Scientists from Duke-NUS Medical School, Singapore have designed a treatment strategy for genetic kidney disease ‘...Read more
Japan uses supercomputer and AI to shed light on drug resistance in cancer treatment
Therapeutics | News | 0 Comment | 07 Mar, 2022
Japan-based Fujitsu and the Tokyo Medical and Dental University (TMDU) have announced a new technology that uses artific...Read more
IASO Bio strengthens manufacturing of CAR-T cell therapy products in China
Therapeutics | News | 0 Comment | 02 Mar, 2022
IASO Biotherapeutics, a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing i...Read more
Thermo Fisher calls for proposals in 'Cancer Molecular Profiling' research
Therapeutics | News | 0 Comment | 01 Mar, 2022
As part of its ongoing commitment to support clinical oncology research, US-based Thermo Fisher Scientific is calling fo...Read more
Korea-based GI Innovation strengthens focus on next-gen innovative immuno-oncology
Therapeutics | News | 0 Comment | 28 Feb, 2022
GI Innovation, based in South Korea, has signed a biomarker joint research MoU with CellKey, a Glycoprotein biomarker de...Read more
Korea develops electronic skin that can feel in real time
Therapeutics | News | 0 Comment | 23 Feb, 2022
A research team at Pohang University of Science and Technology in South Korea, in collaboration with the Department...Read more
Japan proposes framework for conducting ethical research on brain organoids
Therapeutics | News | 0 Comment | 23 Feb, 2022
Researchers from Kobe University and Kyoto University’s Institute for the Advanced Study of Human Biology (WPI-ASH...Read more
Australia invests $23 M for preventive health projects
Therapeutics | News | 0 Comment | 21 Feb, 2022
The Australia government is investing $23 million in three Victorian health projects that will help prevent chronic dise...Read more
Hong Kong finds new inflammatory activation pathway in blood vessels after SARS-CoV-2 infection
Therapeutics | News | 0 Comment | 18 Feb, 2022
A study led by The Chinese University of Hong Kong's (CUHK) Faculty of Medicine (CU Medicine) and the LKS Faculty of Med...Read more
Singapore discovers unique lysin capable of killing deadly multi drug-resistant bacteria
Therapeutics | News | 0 Comment | 17 Feb, 2022
Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-M...Read more
Japan fabricates polymer-DNA gel that could be used in tissue regeneration and robotics
Therapeutics | News | 0 Comment | 17 Feb, 2022
Scientists at Hokkaido University in Japan have made a tuneable, elastic and temperature-sensitive g...Read more
Singapore finds why Alzheimer’s disease females face faster memory decline
Therapeutics | News | 0 Comment | 16 Feb, 2022
A joint study by Nanyang Technological University, Singapore (NTU Singapore) and National University of Singapore (NUS) ...Read more
Japan discovers host immune-dependent novel anti-coronavirus antibody
Therapeutics | News | 0 Comment | 16 Feb, 2022
The National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), in partnership with Shionogi & Co....Read more
Genetic research in NZ offers hope for preventing Parkinson’s disease
Therapeutics | News | 0 Comment | 15 Feb, 2022
There’s new hope for treating Parkinson’s disease with the publication of groundbreaking genetic research fr...Read more